Product Images Annovera

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 18 images provide visual information about the product associated with Annovera NDC 50261-313 by Therapeuticsmd, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - ann00 0000 01

Figure 1 - ann00 0000 01

This text is a chart that displays the number of women with blood clots out of 10,000 woman-years based on different categories: Non-CHC User, Non-Pregnant, CHC User, Pregnancy (limited to 12 weeks only), and Postpartum. There are also ranges for different ages, but their meaning is not clear without additional context.*

Structural Formula Segesterone Acetate - ann00 0000 02

Structural Formula Segesterone Acetate - ann00 0000 02

Structural Formula Ethinyl Estradiol - ann00 0000 03

Structural Formula Ethinyl Estradiol - ann00 0000 03

Figure 2 - ann00 0000 04

Figure 2 - ann00 0000 04

Figure 3 - ann00 0000 05

Figure 3 - ann00 0000 05

Figure - ann00 0000 06

Figure - ann00 0000 06

This text appears to describe pregnancy rates and contraceptive methods. It reports that there are fewer than 1 pregnancy per 100 women in one year, and that 85 or more out of 100 women will not become pregnant in one year. The text lists several contraceptive methods, including implants, injections, intrauterine devices, birth control pills, patches, and vaginal rings with hormones. It also mentions condoms, diaphragms, avoiding sex during the most fertile days of the menstrual cycle, spermicide, and withdrawal as additional contraceptive options.*

Figure - ann00 0000 07

Figure - ann00 0000 07

Figure - ann00 0000 08

Figure - ann00 0000 08

Figure - ann00 0000 09

Figure - ann00 0000 09

Figure - ann00 0000 10

Figure - ann00 0000 10

Figure - ann00 0000 11

Figure - ann00 0000 11

Figure - ann00 0000 12

Figure - ann00 0000 12

Figure - ann00 0000 13

Figure - ann00 0000 13

Figure - ann00 0000 14

Figure - ann00 0000 14

Principal Display Panel - Annovera Carton Label - ann00 0000 15

Principal Display Panel - Annovera Carton Label - ann00 0000 15

ANNOVERA is a vaginal contraceptive that contains 103 mg of segesterone acetate and 174 mg of ethinyl estradiol. The product should be used as prescribed and stored in a controlled environment between 15°C and 30°C. The product should not be frozen and should be kept out of direct sunlight. The package insert includes dosage information for patients. The product should not be used if the seal on the pouch is broken, and unused or used product should not be flushed. *

Principal Display Panel - Annovera Pouch Label - ann00 0000 16

Principal Display Panel - Annovera Pouch Label - ann00 0000 16

ANNOVERA is a vaginal system that provides contraception by delivering a combination of segesterone acetate and ethinyl estradiol at a rate of 0.15 mg/day and 0.013 mg/day, respectively, for 13 cycles. The product does not protect against HIV infection or other sexually transmitted diseases. The vaginal system should not be used if the seal on the pouch is broken, and it should be kept out of reach of children and pets. ANNOVERA should be stored at 20°C to 25°C, with permitted excursions to 15°C to 30°C, and protected from direct sunlight. It should also not be refrigerated or frozen, and neither used nor unused ANNOVERA should be flushed down the toilet. Dosage and administration should be as prescribed. For more details, refer to the package insert.*

Principal Display Panel - Annovera Storage Label - ann00 0000 17

Principal Display Panel - Annovera Storage Label - ann00 0000 17

This is a label for ANNOVERA Storage Case. The user is instructed to fill in the discard date below and attach the sticker to the storage case. The storage case should be discarded 1 year after the first insertion and kept at a temperature between 20°C to 25°C. ANNOVERA should be protected from direct sunlight. The product is distributed by TherapeuticsMD Inc. in Boca Raton, FL 33431. The lot number is XXXXXX ANVA-LAB-20004 4.*

ann00 0000 18

ann00 0000 18

This is a list of studies that provide effect estimates for the use of combined oral contraceptives (COC) in women's health. The studies used different methods to estimate the risk ratio (RR) or odds ratio (OR) between COC use and certain health outcomes. The studies show different results and confidence intervals (CI), indicating uncertainty in the estimation. The text also includes a comparison between current COC users and never-users in some of the studies.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.